Sign in for the best experience.
ORIGINAL RESEARCH
A Mobile Health Intervention to Increase Physical Activity in Pulmonary Arterial Hypertension
Pulmonary Hypertension in Patients With COPD Read the related editorial: Treatment of Pulmonary Hypertension Associated With COPD: Time for Another Look?
Relationship Between Time From Diagnosis and Morbidity/Mortality in Pulmonary Arterial Hypertension Read the related editorial: Time Is of the Essence in PAH Therapy
Association of Bronchopulmonary Dysplasia and Right Ventricular Systolic Function in Young Adults Born Preterm Read the related editorial: The Preterm (Right) Heart: Does Bronchopulmonary Dysplasia Play a Unique Role in Long-term Remodeling?
ST2 Is a Biomarker of Pediatric Pulmonary Arterial Hypertension Severity and Clinical Worsening
CHEST JOURNAL | Access the journal CHEST's full collection of pulmonary vascular disease research. Read the journal »
Hear the lead author of a paper on right ventricular-pulmonary vascular coupling, published in the journal CHEST, discuss this exciting research.
Moderator: Dominique Pepper, MD Panelist: Inderjit Singh, MD
Also available:
CHEST’s clinical guidelines for venous thromboembolism (VTE) disease provide 29 recommendations, covering everything from initial management through secondary prevention and risk reduction of post-thrombotic syndrome.
ACCESS THE GUIDELINES »
Will the new pulmonary hypertension hemodynamic classification temper the PH ‘sex-paradox’? CHEST’s Women’s Lung Health NetWork explores how recent recommended updates to the hemodynamic definition of pulmonary hypertension (PH) will change PH treatment algorithm and outcomes in women compared with men.
Thromboembolism and COVID-19 SARS-CoV-2 infection and COVID-19 pneumonia has been associated with a range of hematological abnormalities. Given these concerns, anticoagulation has been a common therapeutic focus during the pandemic, writes CHEST’s Cardiovascular Medicine and Surgery NetWork.
Heparin’s COVID-19 benefit greatest in moderately ill patients Therapeutic levels of heparin can have widely varying effects on COVID-19 patients depending on the severity of their disease, according to a multiplatform clinical trial that analyzed patient data from three international trials.
The CHEST Foundation creates trusted patient education resources that empower patients to engage in better managing their health.
Navigating PAH: Patient Education Guide PAH Infographic PAH Myths Busted
Don’t miss the premier educational event in chest medicine, including presentations on anticoagulation of venous thromboembolism, pulmonary vascular disease in pregnancy, sarcoidosis-associated pulmonary hypertension, and much more.
Learn about guideline and treatment algorithm updates, diagnostic and therapeutic challenges, and much more.
This online course not only covers the basics of thoracic imaging and airway diseases but also will foster your clinical knowledge, boosting your confidence to respond to complex ICU situations.
CHEST E-LEARNING LIBRARY | Customize a learning plan specific to your needs. Subscribe today »
Written and peer reviewed by renowned experts in the pulmonary, critical care, and sleep medicine fields, the online CHEST SEEK Library and print publications include case-based questions and detailed rationales to stimulate and challenge your clinical thought processes; help you prepare for certification or recertification exams; and allow you to obtain CME credit, MOC points, and CE hours.
CHEST SEEK LIBRARY | Access hundreds of pulmonary, critical care, and sleep medicine questions. Purchase now »
Immerse yourself in a timeless, mobile game of Jeopardy! Test your pulmonary arterial hypertension knowledge by answering the questions on the gameboard surrounding diagnosis and treatment of patients.
Start playing now »
Supporter information can be found in the Player Hub.
If you’re not already a CHEST member, become one today for access to additional resources, discounts on educational activities, and networking opportunities. Join now »